SCHEMBL4338531

SCHEMBL4338531

CCCc1onc(-c2c(Cl)cccc2Cl)c1COc1ccc(-c2ccc3c(C(=O)O)cc(C(=O)O)nc3c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 20/20 0.62
CYP1A2 P05177 2/20 0.58
CYP2C9 P11712 2/20 0.58
NR1I2 O75469 1/20 0.58
CYP3A4 P08684 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4342355 0.89 NR1H4 (0.54) NR1H4CYP1A2CYP2C9NR1I2CYP3A4
SCHEMBL4337362 0.89 NR1H4 (0.77) NR1H4CYP1A2CYP2C9NR1I2CYP3A4
SCHEMBL4335349 0.88 NR1H4 (0.77) NR1H4CYP1A2CYP2C9NR1I2CYP3A4
SCHEMBL2000212 0.87 NR1H4 (0.79) NR1H4CYP1A2CYP2C9NR1I2CYP3A4
SCHEMBL4332555 0.87 NR1H4 (0.77) NR1H4CYP1A2CYP2C9
SCHEMBL4946841 0.87 NR1H4 (0.76) NR1H4CYP1A2CYP2C9NR1I2CYP3A4
SCHEMBL4332513 0.86 NR1H4 (0.77) NR1H4CYP1A2CYP2C9
SCHEMBL4950906 0.86 NR1H4 (0.75) NR1H4CYP1A2CYP2C9NR1I2CYP3A4
SCHEMBL4947994 0.86 NR1H4 (0.76) NR1H4CYP1A2CYP2C9NR1I2CYP3A4
SCHEMBL4339748 0.86 NR1H4 (0.75) NR1H4CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2079307-A2 FARNESOID X RECEPTOR AGONISTS SmithKline Beecham Corporation (US) 2009-07-22 EP claimed
WO-2008051942-A2 FARNESOID X RECEPTOR AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2008-05-02 WO claimed
EP-2079307-A2 FARNESOID X RECEPTOR AGONISTS SmithKline Beecham Corporation (US) 2009-07-22 EP disclosed
WO-2008051942-A2 FARNESOID X RECEPTOR AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2008-05-02 WO disclosed